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14th PATERSON SYMPOSIUM
THE ROLE OF DNA REPAIR IN CHEMICAL CARCINOGENESIS
AT THE PATERSON LABORATORIES, CHRISTIE HOSPITAL AND HOLT
RADIUM INSTITUTE, MANCHESTER, 26-28 SEPTEMBER 1979
The topic for the 14th Paterson Symposium
was chosen in the knowledge that sufficient
experimental information had now accumu-
lated to make this an appropriate time for a
general appraisal of the field. At the same
time an opportunity was provided to evaluate
the technical limitations ofexisting analytical
procedures and to consider the possibilities of
developing more sensitive assay systems
which would ensure further significant pro-
gress in what is already a fruitful area of
investigation.
SYNOPSIS OF PAPERS
On the opening day papers were presented
on the formation and persistence of DNA
adducts. The first speaker was Professor P.
Kleihues (Freiburg) who summarized some
of the evidence that the carcinogenicity of
alkylating agents is determined to a large
extent by their ability to form oxygen-atom
alkylation products in DNA. In many tissues
where tumours are produced by chemical
carcinogens there may be a threshold level of
reaction. In individual tissues, repair ofDNA
lesions may clearly relate to tumour induc-
tion and in some cases may account for tissue
specificity, though it was shown that some
experimental tumour systems do not comply
with this. Some recent data on the interaction
of benzo(oa)pyrene with DNA in various
tissues was also presented, leading to the
conclusion that, unlike alkylating agents,
hydrocarbons may produce different spectra
ofDNA reaction products in different tissues.
Long-term persistence is a common feature
of these adducts, but whilst all adducts are
removed to similar extents within a given
tissue, there are differences in the rate of
removal between tissues.
Dr R. Montesano (Lyon) reported the effect
of chronic administration of dimethylnitros-
amine in enhancing the ability of rat liver
to remove 06-methylguanine from DNA.
This increase in activity was dose-dependent
and required a certain period of treatment to
achieve maximal effect. It was suggested that
the inductive effect resembles that found in
bacteria exposed to low doses of certain
alkylating agents. The effect of chronic
administration of different carcinogens on
DNA repair capacity of tissues was further
explored by Dr G. P. Margison (Manchester).
In several experimental systems, including
chronic administration of diethylnitrosamine
orN-acetyl-aminofluorene toratsordimethyl-
nitrosamine to Chinese hamsters, there was
an increase in the capacity of the liver of
these animals to remove alkylation products.
Since these dose schedules were hepato-
carcinogenic the question arose whether the
enhanced repair was causally related to
tumourproduction.
Dr E. Kriek (Amsterdam) considered
another class of chemical carcinogens and
discussed the promutagenic modifications of
guanine formed by the reactive intermediates
of N-2-fluorenylhydroxylamine. The aryl-
hydroxylamines can be activated to highly
reactive aryl nitrenium ions or aryl nitroside
radicals. Reaction of these intermediates
with DNA may produce multiple forms of
damage to guanine, including base substitu-
tion, removal ofthe modified base to form an
apurinic site or opening of the imidazole ring
of C-8-substituted guanine to form a stable
5(4)-ureido-pyrimidine derivative.
Returning to the theme of alkylation, Dr
P. F. Swann (London) described some experi-
ments in which methylnitrosourea had failed
to produce tumours in the toad, Xenopus
laevis, despite the persistence of 06-methyl-
guanine in tissue DNA, though the long
life-span of these animals precluded a full
interpretation of these experiments. After
presenting his results on the effects ofchronic
administration ofDMN to rats onthecapacity
of the liver to remove 06-methylguanine,
Dr Swann outlined some experiments in
which radioimmunoassay had been used to14th PATERSON SYMPOSIUM
show that there were similar rates of removal
of 06-methylguanine from the satellite and
main-band DNA of the livers of mice given
dimethylnitrosamine.
Dr M. M. Coombs (London) presented his
work on the carcinogenicity and mutagen-
icity of a series of compounds of the cyclo-
penta(oc)phenanthrene series, including some
preliminary results on the rate of loss of
adducts formed by reaction of one of these
compounds with DNA in mouse skin. A
comparison of the binding of a number of
polycyclic compounds to the nuclear vs the
mitochondrial DNA of mouse cells treated in
culture was also described; in allcasesstudied,
the binding to mitochondrial DNA was 50-
100 times higher than to nuclear DNA and
also more non-polar adducts were present in
mitochondrial DNA.
Dr B. W. Stewart (Sydney) described the
kinetics of DNA damage and repair in vivo,
as monitored by chromatography on benzo-
lyated DEAE-cellulose, after administration
of a number of carcinogens. The repair of
06-methylguanine generated by dimethyl-
nitrosamine is associated with extensive
structural damage to DNA. In addition,
short and long "patch" repair may be differ-
entiated in terms of DNA and chromatin
structure. Generally, damage to DNA in any
organ depended on the rate of metabolism of
the carcinogen, the mode of repair, and the
occurrence of cell division.
Dr P. Brookes (Chalfont St Giles) briefly
reviewed the field of hydrocarbon carcino-
genesis, to show how the identification of a
diol-epoxide as the probable ultimate carcino-
gen derived from benzo(cx)pyrene has allowed
considerable advances in the understanding
ofstructure-activity relationships. The avail-
ability ofgeometrical isomers ofthe proposed
ultimate carcinogenicmetabolites, which have
clearly different biological activities, has
provided a method of assessing the relevance
of various reaction products to the carcino-
genic process. Recent results indicate that the
stereoisomers differ in their potency both as
carcinogens and as mutagens.
The first day of the meeting ended with a
review by Professor M. F. Rajewsky (Essen)
of the present concepts of the mechanism of
tumour induction in the rat nervous system
by a pulse of ethylnitrosourea (ENU). The
inability of neural tissue to excise 06-ethyl-
guanine is clearly correlated with its high
susceptibility to malignant transformation.
In animals exposed perinatally, the carcino-
genic effect shows an inverse relationship to
cellular development and/or differentiation,
but a positive correlation with the number of
proliferative neural cells. Using a highly-
sensitive radioimmunoassay the persistence
of06-ethylguanine in the DNA of embryonic
tissues is being measured. This technique can
be extended to the specific detection of other
carcinogen-DNA adducts, and makes it
feasible to study critical DNA lesions after
low levels of carcinogenic exposure.
The morning ofthe second day was devoted
to a consideration ofthe biochemical effects of
carcinogen-DNA modifications, particularly
when present during the synthesis of nucleic
acids. Dr L. A. Loeb (Seattle) detailed two
methods for measuring the accuracy of DNA
synthesis in vitro. One measures the fre-
quency of non-complementary nucleotide
incorporation by DNA polymerases copying
synthetic polynucleotide templates, whilst
the other is a biological assay in which the
DNA polymerase copies a mutant single-
stranded 4X174 DNA that is later used to
infect spheroplasts. These assays have been
used to compare the accuracy of DNA
synthesis by purified enzymes. Changes in
the accuracy of DNA polymerases can arise
in various ways, e.g. by the presence of
apurinic sites in the template DNA, by
different concentrations of DNA precursors
in the assay, by steroid hormones and certain
metal ions or by the presence of terminal
transferase in the assay system. These studies
support the hypothesis that the mechanism
of mutagenesis by certain classes of com-
pounds is at the level ofDNA polymerization.
Professor D. B. Ludlum (Albany) indicated
that chemically different modifications of
DNA can lead to divergent biological effects,
ranging from malignant transformation to
therapeutically useful cytotoxicity. Studies
were made using synthetic polynucleotides
with specific modifications. Using RNA-
synthesizing enzymes, templates containing
06-methylguanine were shown to miscode.
Studies with bischloroethylnitrosourea
(BCNU) which is used therapeutically but
is also carcinogenic have failed to reveal
any reaction at the 06-position of guanine,
but with poly-(cytidylic acid), reaction at
the oxygen of cytosine could be detected.
Cytotoxicity due to BCNU evidently results
from the formation of dinucleoside deriva-
tives, e.g. diguanosinyl ethane. It is conclu-
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agent depends upon the nature of the DNA
modifications which it produces and of their
susceptibility to repair.
Dr B. Singer (Berkeley) listed some of the
chemically stable DNA-carcinogen adducts,
and discussed their removal from DNA in
vivo by enzymic mechanisms, noting that
those adducts which persist during DNA
replication have in many cases been shown
to be mutagenic. In model studies of trans-
cription using polynucleotides containing
small numbers of modified bases, it has been
found that 3-alkylcytosine, 3-alkylthymidine,
1-alkyladenine and all the O-alkylpyrimidines
are transcribed but do not show base specifi-
city, thusexhibitingpartial ortotalambiguity.
This may arise from stacking interactions
that can direct a base into the transcript
without hydrogen bonding.
Dr R. Saffhill (Manchester) described in
vitro systems for DNA synthesis in which
both 04-methylthymine and 06-methylguan-
ine miscode, leading to errors in the newly
synthesized DNA. Other DNA methylation
products, in particular 3-methylcytosine,
02-methylthymine and 3-methylthymine, do
not lead to a detectable number of errors.
The differences obtained for these com-
pounds in RNA- and DNA-synthesizing
assays may reflect differences intheselectivity
of the polymerases used. During DNA
synthesis, miscoding by 06-methylguanine is
competitive with normal incorporation of
cytosine and therefore sizes ofDNA-precursor
pools may be an important factor in carcino-
genesis. When 04-methylthymidine is present
in cell cultures the incorporation of very
small amounts of this modified nucleoside
could be demonstrated, but when adminis-
tered to rats 04-methylthymidine (like 3-
methylthymidine and 02-methylthymidine)
is excreted rapidly in an unchanged form.
During the afternoon of the second day
consideration was given to the nature of the
various repair processes in vivo. Professor W.
G. Verly (Liege) discussed the repair of DNA
containing apurinic sites on incubation with
endonuclease VI, DNA polymerase I and
ligase. Mammalian cells contain several
apurinic endonuclease activities which may
be successive maturation steps in the forma-
tion of the chromatin enzyme, the only one
active on nuclear DNA. Repair deficiencies,
eventually leading to high cancer suscepti-
bility, might depend upon incomplete pro-
cessing of these precursors. Proteins pre-
pared from rat liver nuclei catalyse the
disappearance of 06-ethylguanine from DNA
alkvlated with ethylnitrosourea. Treatment
of a copolymer of deoxythymidylic acid and
06-methyldeoxyguanylic acid with these
same nuclear proteins revealed that this
repair was not due to release of free 06-
methylguanine, but to a more complex
process involving the formation of a residue
that remained in the polynucleotide and the
release of an unidentified molecule.
Professor T. Lindahl (Gothenberg) gave
several examples of the specificity of DNA-
repair enzymes and described their properties
in some detail. DNA glycosylases have been
characterized that act upon DNA and release
either 3-methyladenine or the imidazole-ring
opened form of 7-methylguanine. E. coli
mutants, deficient in the enzyme that
releases 3-methyladenine (tag mutants), are
sensitive to the action of methyl methane-
sulphonate and methylnitronitrosoguanidine,
and have lost their ability to excise 3-methyl-
adenine in vivo. 06-Methylguanine is not
removed by a DNA glycosylase but is altered
to another, possibly non-coding, form in situ
by an inducible E. coli enzyme.
Dr H. W. Thielman (Heidelberg) has
developed a novel systeni which utilizes
ether-permeabilized E. coli cells. With this
system the induction ofrepair by carcinogens
and mutagens has been assessed, and the
enzymic activities involved in the excision
and repair of carcinogen-induced DNA
damage have been examined. Several normal
and xeroderma pigmentosum fibroblast cell
lines have been compared to one another
after exposure to methyl methanesulphonate.
The colony-forming ability and the capacity
to introduce chain breaks into methylated
DNA, but riot apurinic DNA, were diminished
in the xerodermal pigmentosum cells. This may
result from lowered 3-methyladenine DNA
glycosylase activity.
Professor A. E. Pegg (Hershey) gave a de-
tailed appraisal of the enzyme responsible for
removal of 06-alkylguanine from liver DNA
in rodents and humans. This is a unique
enzyme which does not catalyse the removal
of any other alkylated purines. Studies in
vivo over a wide range ofdoses ofthe carcino-
gen dimethylnitrosamine have shown that
the activity is progressively inhibited by the
higher doses. On the other hand, it is stimu-
lated by chronic exposure to low doses.
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Activity is enhanced by growth hormone and
thyroxine and is inhibited by 06-alkyl-
guanines. All of these properties, which were
observed in vivo by following the loss of
labelled 06-methylguanine from DNA after
treatment with dimethylnitrosamine, were
also seen when the liver enzyme was assayed
in vitro. There is evidence that this enzyme
preparation has a limited capacity to catalyse
this reaction, due to the lack of regeneration
ofan essential component.
The meeting ended with a wide-ranging
discussion which included a survey of known
and hypothetical lesions in DNA and their
relevance to the initiation of carcinogenesis.
From the meeting overall, it appears that
very detailed information on the role ofDNA
repair in chemical carcinogenesis has been
obtained by studies with the N-nitroso
compounds and related alkylating agents.
From the analytical data, virtually all the
reactions with DNA have been identified,
and the importance of alkylation of 0-atoms
is now recognized. The potential of specific
lesions to miscode has been established, using
synthetic polynucleotides in vitro. Tissue
differences in the repair of certain DNA
adducts have been studied, and the specific-
ities of these repair enzymes recognized,
together with information on their induction
and inhibition. Studies have been made on
selected compounds from the other important
classes of chemical carcinogens, polycyclic
hydrocarbons and derivatives of aromatic
amines. Several sites of reaction with DNA
have been identified, though the analysis is
not yet complete. There is evidence of long-
term persistence of specific carcinogen-DNA
adducts, and tissue differences in the repair
of these lesions are under investigation.
Progress has been made in improving the
chromatographic procedures. However, the
preparation of high-affinity antibodies for
06-ethyldeoxyguanosine, allowing the detec-
tion of sub-picomole quantities suggests that
radioimmunoassay may provide a rapid and
much more sensitive technique for the
detectionofspecificcarcinogen-DNA adducts.
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